Skip to main content
OpenTrials
Not yet recruiting

NCT Number: NCT07790588

Project Leo: Trauma-Informed Yoga for Preschool Children and Parents

The goal of this pilot clinical trial is to examine feasibility, acceptability, and direction of effect of a dyadic (child and parent) trauma-informed yoga intervention on stress symptoms and sleep in young children (age 3-6) after war. The main questions it aims to answer are:

* Is the intervention feasible and liked by the participants? * Does the child-parent yoga intervention reduce the child's stress symptoms and improve their sleep? * Does the child-parent yoga intervention improve the child-parent relationship?

Participants (child-parent dyads) will:

* Children and parents will participate together in 8 weekly group yoga sessions. * Children and parents will engage together in a short daily at-home practice before bedtime. * Parents will complete online surveys before and after the 8-week program, and at one-month follow-up. * Parents will complete a daily practice-sleep log.

Not yet recruiting

Trial opening soon.

Get Notified

Key information

Age range

3 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Tel Aviv University, Tel Aviv, Israel

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Children: Age 3-6. Per the parent's report, the child exhibits at least one stress-related symptom.

Parents: Preferably, the same parent can attend all group sessions. Having internet access at home to complete online surveys.

Exclusion criteria

Children: Any physical disability that prevents participating safely in yoga sessions.

Parents: Self-reported pregnancy. Any physical disability that prevents participating safely in gentle yoga sessions.

Treatment and study plan

Dyadic (Child-Parent) Yoga

Behavioral

Participants will attend 8 weekly group sessions of dyadic (child and parent) yoga and engage in at-home practice at bedtime.

Primary outcomes

  1. Child's Stress Symptoms

    Time frame: 8 weeks

    Presence and severity of stress symptoms will be assessed (parent-reported) using the Young Child PTSD Checklist (YCPC). The 30-item scale yields a sum score ranging from 0 to 120, with higher scores indicating more severe stress symptoms.

  2. Child's Sleep Quality

    Time frame: 8 weeks

    The child's sleep quality will be assessed (parent-reported) using the Children's Sleep Habits Questionnaire Abbreviated (CSHQ). The 22-item scale yields a sum score ranging from 0 to 88, with higher scores indicating more severe sleep problems.

Secondary outcomes

  1. Child-Parent Relationship: Closeness

    Time frame: 8 weeks

    The quality of the child-parent relationship will be assessed (parent-reported) using the Child-Parent Relationship Scale - Short Form (CPRS-SF), specifically the Closeness subscale. The 7-item subscale yields a sum score of 7 to 35, with higher scores indicating greater closeness. Higher closeness scores reflect better relationship between the child and the parent.

  2. Child-Parent Relationship: Conflict

    Time frame: 8 weeks

    The quality of the child-parent relationship will be assessed (parent-reported) using the Child-Parent Relationship Scale - Short Form (CPRS-SF), specifically the Conflict subscale. The 8-item subscale yields a sum score of 8 to 40, with higher scores indicating greater conflict. Lower conflict scores reflect better relationship between the child and the parent.

  3. Parent's Stress Symptoms

    Time frame: 8 weeks

    Presence and severity of post-traumatic stress symptoms will be assessed (self-reported) using the PCL-5 scale. The 20-item scale yields a sum score ranging from 0 to 80, with higher scores indicating more severe post-traumatic stress symptoms.

  4. Parent's Sleep Quality

    Time frame: 8 weeks

    The parent's sleep quality will be assessed (self-reported) using the Sleep Disturbance PROMIS SF 8b. The 8-item scale yields a sum score ranging from 8 to 40, with higher scores indicating more severe sleep problems.

  5. Parental Self-Efficacy

    Time frame: 8 weeks

    The parent's self-confidence in their ability to handle their child's behavior problems will be assessed (self-reported) by the Brief Parental Self-Efficacy Scale. The 5-item scale yields a sum score ranging from 5 to 20, with higher scores indicating greater self-confidence.

  6. Child's Pain Severity

    Time frame: 8 weeks

    If the child experiences pain, pain severity will be assessed (parent-reported) using one item from the Brief Pain Inventory (BPI). Pain severity will be rated on a scale from 0 to 10, with higher rating indicating more severe pain.

  7. Child's Pain Interference

    Time frame: 8 weeks

    If the child experiences pain, pain interference with routine activities will be assessed (parent-reported) using one item from the Brief Pain Inventory (BPI). The level of how much the pain interferes with routine activities will be rated on a scale from 0 to 10, with higher ratings indicating greater interference.

  8. Parent's Pain Severity

    Time frame: 8 weeks

    If the parent experiences pain, pain severity will be assessed (self-reported) using one item from the Brief Pain Inventory (BPI). Pain severity will be rated on a scale from 0 to 10, with higher rating indicating more severe pain.

  9. Parent's Pain Interference

    Time frame: 8 weeks

    If the parent experiences pain, pain interference will be assessed (self-reported) using two items from the Brief Pain Inventory (BPI). The level of how much the pain interferes with (a) enjoyment in life and with (b) routine activities will be rated on a scale from 0 to 10, with higher ratings indicating greater interference.

Other outcomes

  1. Feasibility: Recruitment

    Time frame: Recruitment period, from initiation until the start day of the intervention

    Recruitment will be calculated as the proportion of enrolled participants to interested individuals during the recruitment period.

  2. Feasibility: Intervention Retention

    Time frame: 8 weeks

    Retention will be calculated as the proportion of participants who completed the intervention to participants who gave their consent to participate.

  3. Feasibility: Intervention Adherence

    Time frame: 8 weeks

    Percentage of participants completing at least 75% of the group sessions AND at least 4 at-home practices per week. Group session attendance will be monitored by the research team. At-home practice will be self-reported via a daily practice log.

  4. Acceptability: Liking

    Time frame: 8 weeks

    Parents will be asked if they liked the intervention on a scale of 0 to 10, with higher ratings indicating greater liking and better acceptability of the intervention among parents.

  5. Acceptability: Recommending

    Time frame: 8 weeks

    Parents will be asked about the likelihood that they would recommend the program to others, rated from 0 to 100%, with higher ratings indicating a greater likelihood of recommending the intervention and better acceptability of the intervention among parents.

Study contacts

Contact information is provided by the study sponsor or research team.

Noga Tsur, PhD

CONTACT

[email protected]

Shahar Almog, PhD

CONTACT

[email protected]

+1 (561) 2973461

Sponsors and collaborators

Lead sponsor

Florida Atlantic University

Other

Collaborators

  • Tel Aviv University

Registry information

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Aug 27, 2026
Registry last updated
Aug 27, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.